Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
Cancer Immunol Immunother
; 60(5): 715-30, 2011 May.
Article
in En
| MEDLINE
| ID: mdl-21331814
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Granulocyte-Macrophage Colony-Stimulating Factor
/
Paclitaxel
/
Cancer Vaccines
/
Antineoplastic Agents, Phytogenic
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2011
Type:
Article
Affiliation country:
China